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Abstract
Cell–cell and cell–matrix interactions guide organ development and
homeostasis by controlling lineage specification and maintenance,
but the underlying molecular principles are largely unknown. Here,
we show that in human developing cardiomyocytes cell–cell
contacts at the intercalated disk connect to remodeling of the actin
cytoskeleton by regulating the RhoA-ROCK signaling to maintain an
active MRTF/SRF transcriptional program essential for cardiomyo-
cyte identity. Genetic perturbation of this mechanosensory path-
way activates an ectopic fat gene program during cardiomyocyte
differentiation, which ultimately primes the cells to switch to the
brown/beige adipocyte lineage in response to adipogenesis-
inducing signals. We also demonstrate by in vivo fate mapping and
clonal analysis of cardiac progenitors that cardiac fat and a subset
of cardiac muscle arise from a common precursor expressing Isl1
and Wt1 during heart development, suggesting related mecha-
nisms of determination between the two lineages.
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Introduction
Developmental commitment of cells and tissues is governed by
combinations of lineage-specific transcription factors that act as
master switch genes defining and reinforcing cell type-specific gene
expression patterns. It has been demonstrated that artificial ectopic
expression of lineage-specific master genes is sufficient to reprogram
one cell type into another, both in vitro and in vivo (Takahashi et al,
2007; Pang et al, 2011; Ahfeldt et al, 2012; Qian et al, 2012). In
some vertebrates and invertebrates, conversion between cell types
takes place naturally during developmental and regeneration
processes in response to local signals (Sisakhtnezhad & Matin,
2012). In humans or mammals, only limited evidence suggests that
spontaneous cell fate changes could occur under pathological condi-
tions (Park et al, 2006; El Agha et al, 2017; Plikus et al, 2017).
Learning the molecular principles of natural cell lineage conversion
will be critical for understanding how to reset cellular identities for
application in cell therapy and regenerative medicine.
Direct transdifferentiation of cardiac muscle cells into adipocytes
has been postulated in arrhythmogenic right ventricular cardiomyo-
pathy (ARVC; d’Amati et al, 2000), a heritable cardiac disease
pathologically characterized by fibroadipocytic replacement of
cardiac myocytes (CMs) leading to right ventricular failure, arrhyth-
mias, and sudden cardiac death (Basso et al, 2009). Mutations in
genes encoding proteins of the desmosome and the area composita
are collectively responsible for ~50% of ARVC cases (Delmar &
McKenna, 2010). Elegant lineage-tracing studies in mice harboring
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conditional ablation of the desmosomal protein desmoplakin in
adult CMs or embryonic cardiac progenitors have provided first
evidence that pathological fat in ARVC can arise from mature CMs,
and this process is “primed” early during organogenesis (Lombardi
et al, 2009). As the heart is constantly exposed to a high level of
mechanical strain from the beginning of its development, this
suggests that coordination of cell adhesion is likely a key process
whereby mechanics could regulate cellular identity of CMs. Indeed,
cell–cell and cell–matrix contacts are known to integrate with
cytoskeletal organization to influence response to mechanical cues
and regulate developmental fate and lineage specification. However,
whether similar principles also operate during cell lineage conver-
sion remains elusive.
Here, we used CMs from ARVC patients harboring cell–cell adhe-
sion defects to evaluate the role of mechanical sensing in controlling
cardiac muscle identity and elucidate how force-bearing cell–cell
contacts link to changes of transcriptional programs during patho-
logical myocyte-to-adipocyte switch. Furthermore, using in vivo fate
mapping and clonal analysis of cardiac progenitors we show that
cardiac fat and a subset of CMs arise from a common Isl1/Wt1-
expressing precursor during development.
Results
CMs carrying pathological mutations in desmosomal proteins
convert into brown/beige adipocytes in vitro
We generated induced pluripotent stem cells (iPSCs) from an ARVC
patient who carried a heterozygous frameshift mutation (c.1760delT;
p.V587Afs*655) in the PKP2 gene encoding the desmosomal protein
plakophillin (Appendix Fig S1). We coaxed iPSCs to differentiate into
CMs with a ~97% purity and analyzed the ability of CMs to convert
into adipocytes when cultured under conditions mimicking the
mechanical strain of the heart (50 kPa substrate stiffness and 1 Hz
electrical pacing) and exposed to a lipogenic milieu favoring the fatty
acid oxidation-based metabolism found in both adult CMs and
adipocytes (see Materials and Methods).
Mutated CMs had normal levels of PKP2 transcript (Fig EV1A),
but plakophillin protein was reduced by up to 50% compared to
wild-type (wt) control cells, with no C-terminal truncated form
detectable (Fig EV1B). Consistently, immunohistochemistry
revealed decreased PKP2 expression at the plasmamembrane,
concurring with a thin and interrupted desmosome structure
(Fig 1A). Such alterations at the intercalated disks were further con-
firmed by immunodetection of desmoplakin (Fig EV1C), indicating
defects of mutant CMs in establishing cell–cell junctions.
Immunofluorescence analysis of cardiac troponin T (cTNT), a
protein marking CM sarcomeres, in conjunction with the lipid stain
Oil Red O (ORO) revealed gradual morphological and structural
changes in diseased CMs over time in culture (Fig 1B). While wt
cells showed a stable myocytic phenotype over a 4-week period with
only little lipid accumulation indicative of lipogenesis, a progressive
disarray of myofilaments and development of enlarged multilocular
lipid droplets were detected in mutated CMs (Fig 1B–D), suggesting
an ongoing loss of myocytic identity and acquisition of fat cell
phenotype. Lipid-filled adipocyte-like cells lacking sarcomeres and
morphologically resembling brown/beige adipocytes (multilocular
lipid droplet morphology) were observed in mutated cells from day
21, with their number increasing over time (Fig 1B and E).
Quantitative RT–PCR for a panel of CM, preadipocyte, and adipo-
cyte markers confirmed that the morphological transformation of
PKP2 mutant CMs indeed was accompanied by concurrent changes
in cell type-specific gene expression (Fig 1F). Interestingly, when
compared to wt CMs, mutated cells at baseline (i.e., before initiation
of pacing and culture in lipogenic milieu) already expressed higher
levels of key genes directing preadipocyte differentiation, such as
PPARc, C/EBPa (Farmer, 2006), and PRDM16, a transcriptional regu-
lator of PPARc that specifies the brown fat lineage (Seale et al,
2008). Moreover, TCF21, a transcription factor that is expressed in
preadipocytes and has been shown to suppress myogenesis
(Timmons et al, 2007), was also upregulated in mutated CMs,
suggesting that mutants might be less faithfully restricted to the CM
phenotype and already primed for the adipocyte lineage. In mutant
cultures, genes of terminally differentiated adipocytes, such as
FABP4 and ADIPOQ (Gesta et al, 2007), became progressively
upregulated over time, while CM genes (TNNT2, MYH7, and
ACTC1) were gradually downregulated (Fig 1F). Genes associated
with apoptosis (BAX1, BIM, and FAS) remained unchanged
(Fig EV1D), suggesting that the morphological/structural and tran-
scriptional changes seen in the pathological settings were not conse-
quences of apoptotic death and selection but rather the result of cell
type conversion. Intriguingly, in addition to PRDM16, other brown/
beige-fat-cell-specific genes, including UCP1, CIDEA, and ELOVL3
(Cohen & Spiegelman, 2015; Ikeda et al, 2018), showed elevated
expression after prolonged culture of mutant CMs, whereas genes
enriched in white fat (FBN1 and NRIP1; Gesta et al, 2007) were not
upregulated (Fig EV1D). Remarkably, expression levels of brown/
beige adipocyte markers in mutated cells were comparable to those
measured in human iPSC-derived brown/beige adipocytes (Ahfeldt
et al, 2012; Guenantin et al, 2017; Fig EV1E), suggesting a “true”
conversion toward the brown/beige fat lineage.
To address the stability of the myocyte-to-adipocyte switch in
pathological conditions, we cultured wt and mutated cells for up to
4 additional weeks and evaluated the expression of PPARc and
cTNT as well as the exhibition of a mature functional brown/beige
adipocyte phenotype. Immunofluorescence analysis for PPARc, a
master regulator of adipogenesis, in conjunction with lipid BODIPY
stain at 8-week culture revealed that roughly 40–50% of mutant
cells maintained the morphological appearance of mature brown/
beige adipocytes, expressed high levels of nuclear PPARc, and were
negative for cTNT (Fig 1G). In contrast, wt cells lacked PPARc and
kept the typical myocytic phenotype with well-organized cTNT+
sarcomeres and regular contractions (Fig 1G). Furthermore, the
ability to break down triglycerides and release glycerol was signifi-
cantly higher in mutant cells compared to control and further
increased upon forskolin treatment (Fig 1H), indicative of functional
adipocytes. As characteristic feature, brown/beige adipocytes carry
out efficient thermogenesis under b-adrenergic stimulation (Cereijo
et al, 2015). Consistently, upregulation of thermogenic genes upon
treatment with 8-Br-cAMP was similar between mutant cells and
iPSC-derived brown/beige adipocytes (Fig EV1F), confirming a
brown/beige fat identity of the converted cells.
Taken together, these results indicate that a direct conversion of
CMs into adipocytes with brown/beige fat identity can take place in
the presence of pathological mutations that weaken cell–cell
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adhesion. Considering that the efficiency of the conversion process
is only ~40%, we reasoned that a certain subpopulation of CMs
might be “primed” for remodeling of transcriptional networks
depending on pre-existing transcriptional or epigenetic status likely
acquired during the cell fate specification processes throughout
organ development.
Cardiac fat and a subpopulation of CMs share common
embryonic Isl1/Wt1-expressing progenitors
To address directly whether a common progenitor exists between a
subset of CMs and fat cells, we performed lineage-tracing
experiments in mice. Human pathological cardiac adipogenesis in
ARVC occurs mainly in the right ventricle (RV), which arises from a
specific population of cardiac progenitors—known as second heart
field (SHF) progenitors—marked by the transcription factor Isl1.
Thus, we crossed mice that express the Cre recombinase under
control of the Isl1 locus (Isl1Cre/+; Yang et al, 2006) with double-
fluorescent Cre reporter mice, in which transgene expression of
membrane-targeted tdTomato (mT) from the Rosa26 locus converts
to expression of membrane-targeted green fluorescent protein (mG)
in a Cre-dependent manner (R26mTmG/+), allowing tracing of Isl1-
expressing descendants by mG expression. Highly efficient mG
labeling was observed in RV CMs and in the vast majority of
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Figure 1. CMs with pathological PKP2 mutation convert into adipocytes in vitro.
A Immunostaining of cTNT (green) and PKP2 (red) in wt and PKP2mut CMs. Scale bars, 25 lm. Insets show a magnified image of PKP2 expression; scale bars, 10 lm.
B Immunodetection of cTNT (blue) and lipid stain ORO (red) in wt and PKP2mut CMs over time in culture. Scale bars, 50 lm.
C–E Bar graphs show the percentage of cTNT+/ORO+ cells (C), cTNT+/ORO+ cells with organized (org), disorganized (disorg) and dissolving sarcomeres (loss) (D), and
adipocyte-like cells (E) in wt and PKP2mut CMs over time (n = 3; N = 45–300 cells per time point in each group; *P < 0.05, **P < 0.001 vs. wt at the same time
point; t-test).
F qRT–PCR analysis of myocytic and adipocytic genes in wt and PKP2mut CMs over time in culture (n = 3; *P < 0.05, **P < 0.01, ***P < 0.001 vs. wt at the same
time point, t-test).
G Immunodetection of cTNT (magenta) and lipid stain BODIPY (green) in wt and PKP2mut CMs after 8 weeks of culture. Scale bars, 50 lm. Lower panels show
magnified images of areas indicated by the white box for BODIPY (green) and PPARc (red). Scale bars, 25 lm.
H Glycerol release of wt and PKP2mut CMs after 8 weeks in culture in the absence or presence of 10 lM forskolin (n = 3; *P < 0.01 vs. wt; t-test).
Data information: All data are shown as means  SEM.
Source data are available online for this figure.
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perilipin (Plin1)-positive cells of cardiac fat depots—which are
known to have brown character and are limited to a very specific
location between the atrial and ventricular chambers on the dorso-
lateral sides of the heart (called AV groove; Yamaguchi et al, 2015;
Fig 2A). AV groove fat originates from the proepicardial organ
(PEO), a transient extra-cardiac cluster of progenitors that arises
between embryonic day (E) 9 and 10.5 at the ventro-caudal base of
the developing mouse heart (Liu et al, 2014; Yamaguchi et al,
2015). PEO contributes cells to various cardiac lineages and is
marked by expression of multiple genes, including the transcription
factor Wilm’s tumor 1 (Wt1; Brade et al, 2013; Risebro et al, 2015).
Immunofluorescence analysis for Isl1 and Wt1 in the PEO of
Isl1Cre/+;R26mTmG/+ embryos at E9.5 revealed expression of the
lineage marker mG in almost half of the Wt1+ cells (44  5%,
n = 5 embryos) and complete absence of Isl1 expression throughout
the tissue (Fig 2B), suggesting that a subset of Wt1+ proepicardial
cells derive from Isl1+ progenitors that have turned off Isl1 at the
PEO state. Indeed, co-staining of Wt1 and Isl1 proteins at develop-
mental stages preceding PEO formation identified a rare population
of double Wt1/Isl1-expressing cells in the caudal lateral mesoderm
at E8 (50–70 cells/embryo, Fig 2C). We traced the descendants of
these cells using inducible Isl1MerCreMer/+ and Wt1CreERT2/+ mice, in
which Cre recombinase requires tamoxifen to be active (Feil et al,
1997; Laugwitz et al, 2005). We performed maternal injection of
low doses of tamoxifen at E7.5 and analyzed E9.5 embryos and
4-week postnatal hearts. At E9.5, we found an overlap of mG+ cells
between the two mouse lines in the epicardium, a PEO derivative,
while exclusive marking of SHF progenitors/cardiac myocytes and
PEO progenitors was observed in the Isl1MerCreMer/+;R26mTmG/+ and
Wt1CreERT2/+;R26mTmG/+ lines, respectively (Fig EV2). Examination
of adult hearts demonstrated mG labeling of both AV groove adipo-
cytes and CMs in 22% of Isl1MerCreMer/+;R26mTmG/+ and 86% of
Wt1CreERT2/+;R26mTmG/+ animals analyzed (Figs 2D and EV3).
Furthermore, other cardiac lineages known to originate from PEO
progenitors expressed mG in Wt1CreERT2/+;R26mTmG/+ adult mice
(Appendix Fig S2A), confirming that tamoxifen injection at E7.5
labels true Wt1+ proepicardial precursors prior to the development
of the PEO. No activation of Cre was observed in absence of tamox-
ifen (Appendix Figs S2B and S3).
To assess the differentiation potential of early double Isl1+/
Wt1+ progenitors into the myocytic and adipocytic lineages at the
clonal level, we took advantage of mouse embryonic stem cells
(ESCs) and of a cardiac mesenchyme culture (CMC) system that
we previously established to efficiently promote the self-renewal
of early Isl1+ cardiac precursors (Laugwitz et al, 2005; Moretti
et al, 2006; Qyang et al, 2007). We derived ESCs from the blasto-
cysts of Isl1Cre/+ mice crossed with the R26YFP/+ indicator mice
that express yellow fluorescent protein (YFP) from the Rosa26
gene locus upon Cre-mediated recombination (Fig 3A). Within
4–5 days of embryoid body (EB) differentiation, the first Isl1+
progenitors arose, as demonstrated by YFP expression and
detection of Isl1 transcript (Fig 3B and C). This coincided with the
upregulation of other key markers of early cardiac progenitors,
such as Nkx2-5 and Gata4 (Moretti et al, 2006; Wu et al, 2006;
Fig 3C). Fluorescence-activated cell sorting (FACS) of YFP+ cells
from 4d EBs, followed by exposure to pro-myogenic or pro-adipogenic
culture conditions, demonstrated the differentiation potential of
this population into CMs and adipocytes (Fig 3D and E). We
then clonally expanded single FACS-sorted Isl1/YFP-expressing
precursors on CMC feeder layers and analyzed their bi-differentiation
potential and gene expression profile (Fig 3A). Immunohisto-
chemistry analysis after 6 days of co-culture revealed that ~50%
of YFP+ clones co-expressed Isl1 and Wt1 (Fig 3F). Interestingly,
when induced to differentiate, only clones that expressed both Isl1
and Wt1 gave rise to the two lineages, as demonstrated by the
appearance of striated muscle cells expressing cTNT and lipid-
filled adipocytes expressing PPARc (Fig 3G and H). Differentiation
into one lineage was observed only for CMs, triggered in clones
that were exclusively positive for Isl1 and Nkx2-5, a key marker
of myocytic fate (Moretti et al, 2006; Wu et al, 2006; Fig 3H).
Moreover, further treatment of differentiating CM cultures with
pro-adipogenic medium induced significant accumulation of lipid
droplets merely in CMs from Isl1+/Wt1+ clones (Appendix Fig
S4), indicating a higher plasticity of these CMs toward the adipo-
cytic fate.
Taken together, these results suggest that the molecular signa-
ture of Isl1+/Wt1+ defines a cardiac “myo-adipo progenitor cell”
in vitro, which is distinct from Isl1+/Nkx2-5+ myocytic precursors.
Furthermore, they hint to an important role of Wt1 in program-
ming Isl1+ cardiac precursors into the adipogenic lineage and a
possible involvement in “priming” CMs to spontaneously adopt a
brown/beige adipocyte phenotype in specific disease-associated
conditions.
WT1 is activated during pathological myocyte-to-adipocyte
conversion but is not sufficient to induce PPARc, the molecular
trigger of the adipogenic phenotype
To investigate the potential contribution of WT1 to the pathological
myocyte-to-adipocyte lineage conversion observed in PKP2 mutant
CMs, we first analyzed its expression and cellular distribution before
and during induction of the adipocyte switch (Fig 4A). WT1 is
predominantly a nuclear protein in most expressing tissues and
functions both as a transcriptional activator/co-activator or repres-
sor of gene expression (Hohenstein & Hastie, 2006); however, owing
to its ability to bind RNA (Hohenstein & Hastie, 2006) and actin
(Dudnakova et al, 2010), it can also be detected in the cytoplasm of
many cells, mainly localized on cytoskeleton-bound polysomes
(Dudnakova et al, 2010). Interestingly, differently from mouse CMs
that lack expression of Wt1 at both embryonic and adult stages
(Zhou et al, 2008), a strong WT1 cytoplasmic immunostaining
signal has been reported in developing CMs of human fetuses
(Ambu et al, 2015).
Immunocytochemistry in human iPSC-derived CMs demon-
strated expression of WT1 in both wt and PKP2 mutated cells, which
was predominantly localized in the cytoplasm in a filament-like
pattern (Figs 4A, and EV4A and B). Remarkably, WT1 transcript
and protein levels were significantly higher in PKP2 mutant CMs
(Figs EV4A and B, and 4A). Moreover, lipogenic culture conditions
induced nuclear translocation of WT1 exclusively in mutated cells,
which ultimately coincided with marked myofibril disarray and
PPARc activation (Fig 4A). In line with these observations,
immunohistological inspection of WT1 expression in adult human
myocardium from ARVC patients revealed a nuclear localization of
WT1 protein in some of the CMs adjacent to the fibrofatty tissue,
while only cytosolic-localized protein could be detected in heart
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Figure 2. Cardiac muscle and fat derive from Isl1/Wt1-expressing progenitors.
A Immunofluorescence analysis of Isl1 derivatives in Isl1Cre/+;R26mTmG/+ mouse hearts at postnatal d28 (P28): Plin1 (magenta), membrane GFP (mG, green), and
membrane Tomato (mT, red). The three panels on the right show a magnified view of the area indicated by the white box in the left panel. Arrows indicate Plin1+/
mG+ adipocytes. la, left atrium; lv, left ventricle; ra, right atrium; rv, right ventricle. Scale bars, 500 lm (left panel), 25 lm (right panels); n = 3.
B Immunostaining of cTNT, Isl1 or Wt1 (all magenta), mG (green), and mT (red) in sagittal, sequential sections of Isl1Cre/+;R26mTmG/+ embryos at E9.5. The boxed region
in panel a is shown at higher magnification in the consecutive section in bI. cI and cII are magnifications of the boxed area in bI (in consecutive sections). Isl1-Cre-
mediated mG labeling was observed in CMs of the forming heart (a, box b), cardiac progenitors (bI, marked by the asterisk), and a proportion of Wt1+ proepicardial
cells in the PEO (cI, indicated by arrows, and cII). Scale bars, 250 lm (a), 150 lm (bI), 25 lm (cI and cII); n = 3.
C Immunostaining for Isl1 and Wt1 in transverse sections of E8 embryos. A representative section corresponding to the position indicated by the dashed line drawn
through the adjacent embryo view (i) is shown in panel ii after Hoechst 33258 staining of nuclei (blue). Panels iii show the boxed area in panel ii after Isl1 (red) and
Wt1 (green) co-immunostaining. Isl1+/Wt1+ progenitors and marked by the arrows in (iii). Scale bars, 2 mm (i), 200 lm (ii), 10 lm (iii). ca, caudal; cr, cranial; d, dorsal;
fg, foregut; ht, heart; l, left; nt, neural tube; r, right; v, ventral; n = 3.
D Temporal restriction of Cre-mediated labeling of Isl1+ and Wt1+ progenitors and their derivatives using tamoxifen-inducible Isl1MerCreMer/+;R26mTmG/+ and Wt1CreERT2/+;
R26mTmG/+ mouse lines. Labeling was induced by tamoxifen treatment at E7.5, and heart sections were analyzed at postnatal day 28 (P28). Shown are representative
immunostainings of cTNT or PLIN1 (magenta), mG (green), and mT (red) in sections of Isl1Cre/+;R26mTmG/+ (left panels) and Wt1CreERT2/+;R26mTmG/+ (right panels). Arrows
indicate cTNT+/mG+ CMs. Scale bars, 25 lm; n = 3 per genotype.
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Figure 3. A single Isl1/Wt1-expressing progenitor gives rise to both CMs and adipocyte lineages in vitro.
A Scheme for isolation of Isl1+/YFP+ cardiac precursors from the blastocyst-derived mouse Isl1Cre/+;R26YFP/+ ESCs and their clonal analysis.
B, C Assessment of YFP expression by bright field/epifluorescence microscopy (B) and qRT–PCR analysis of cardiac progenitor markers (C) during EB differentiation of
Isl1Cre/+;R26YFP/+ ESCs. Scale bars, 200 lm; n = 4; *P < 0.05, **P < 0.01 vs. d0; t-test. Data are shown as means  SEM.
D Flow cytometry analysis of YFP expression and qRT–PCR analysis of cardiac progenitor markers in YFP+ and YFP cells sorted from 4-day-old Isl1Cre/+;R26YFP/+ EBs.
FITC, fluorescein isothiocyanate; PE, phycoerythrin. n = 3; *P < 0.05 vs. YFP; t-test. Data are shown as means  SEM.
E Immunostaining of cTNT (red) and PPARc (red) in conjunction with lipid stain BODIPY (green) of sorted cells from 4-day-old Isl1Cre/+;R26YFP/+ EBs after
differentiation in pro-myogenic and pro-adipogenic culture conditions. Scale bars, 50 lm. The insets show higher magnifications, scale bars, 25 lm.
F Immunostaining of Isl1 (cyan), Wt1 (red), and YFP (green) in a representative clone derived from a single Isl1+ progenitor sorted from 4-day-old Isl1Cre/+;R26YFP/+ EBs
and expanded on CMCs for 6 days. Scale bar, 100 lm.
G Immunostaining of cTNT (red) and PPARc (red) in conjunction with BODIPY (green) in cell derivatives from a single Isl1+/Wt1+ clone after differentiation in pro-myogenic
(left) or pro-adipogenic (right) culture conditions for 6 and 28 days, respectively. Scale bars, 50 lm. The inlays show higher magnifications; scale bars, 25 lm.
H RT–PCR profile of 10 representative clones after expansion on CMCs for 6 days. Isl1+/Wt1+ clones differentiated into both adipocytic and myocytic lineages, and
Isl1+/Nkx2-5+/Wt1 clones differentiated only into the myocytic lineage. CMC cDNA was used as a negative control. Adipo, adipocytes; CMC, cardiac feeder cells; L,
DNA ladder; Myo, myocytes.
Source data are available online for this figure.
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Figure 4. Cooperative role of WT1 and PPARc in cardiomyocyte-to-adipocyte conversion.
A Immunostaining of endogenous WT1 (magenta), F-actin (Phalloidin, green), and PPARc (red) in wt and PKP2mut CMs at 0 and 28 days in culture. Arrows indicate
PKP2mut cells with nuclear translocation of WT1, sarcomere disarray, and PPARc activation. Scale bars, 25 lm.
B, C Immunocytochemistry of wt CMs after 28-day infection with lentiviral constructs encoding the nuclear-tagged form of WT1 (NLS-WT1) plus GFP or GFP alone
showing GFP (green), cTNT (red) and PPARc (magenta) (B), and GFP (green, left) and cTNT (blue) in conjunction with lipid stain ORO (red, right) (C). Scale bars,
25 lm (B) and 50 lm (C).
D–F Immunocytochemistry of wt CMs after lentiviral overexpression of PPARc alone (PPARcOE, D), PPARc and NLS-WT1 (NLS-WT1/PPARcOE, E) or PPARc, and shRNA
targeting WT1 (shWT1/PPARcOE, F) at 14 (top) and 21 (bottom) days after infection. All constructs co-express GFP. Representative images show GFP (green, left)
and cTNT (blue) in conjunction with ORO stain (red, right) in the same cells. Scale bars, 50 lm.
G, H qRT–PCR analysis of myocytic and adipocytic genes in PPARcOE (G), NLS-WT1/PPARcOE (H), and shWT1/PPARcOE (H) conditions at the indicated time points; n = 3
(PPARcOE, NLS-WT1/PPARcOE) and n = 4 (shWT1/PPARcOE). *P < 0.05, **P < 0.01, ***P < 0.001 vs. GFP control (G) or PPARcOE (H) at the same time point (t-
test). Data are shown as means  SEM.
I Wt CMs were transduced with HA-tagged PPARc and NLS-WT1 and cultured in adipogenic medium for 14 days. Nuclear cell lysates were precipitated using anti-
HA or anti-WT1 followed by immunoblot (IB) analysis with an anti-WT1 or anti-PPARc, and IgG was used as control; n = 3. Arrows indicate WT1 (left panel) and
PPARc (right panel) bands.
Source data are available online for this figure.
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tissue samples from individuals lacking mutations in cell–cell junc-
tional proteins (Fig EV4C and D).
We next explored whether nuclear shuttling of WT1 would be
sufficient to induce PPARc expression and whether PPARc functions
as myocyte-to-adipocyte-specific master switch. We transduced wt
CMs with lentiviral constructs encoding either a nuclear-tagged form
of WT1 (NLS-WT1) or PPARc together with GFP or GFP alone (as
control; Appendix Fig S5A and B) and analyzed the morphological
and molecular dynamic changes occurring during culture of the cells
in lipogenic milieu. We obtained a transduction efficiency of ~80%,
as measured by the percentage of GFP+ cells expressing nuclear
WT1 or PPARc (Appendix Fig S5A and B). Upon overexpression of
NLS-WT1, CMs maintained a stable myocytic phenotype with well-
organized sarcomeres (Fig 4B and C). No activation of PPARc or
other adipogenic-specific genes (Fig 4B and Appendix Fig S5C) nor
appearance of lipid droplets was observed even after prolonged
culture (Fig 4C), suggesting that nuclear localization of WT1 is not
sufficient to induce myocyte-to-adipocyte conversion in wt settings.
However, forced expression of PPARc resulted in myofibril disar-
rangement and C/EBPa activation in all infected CMs by 7 days
(Appendix Fig S5D). Within 3 weeks, the vast majority of PPARc-
infected CMs had lost cTNT expression and acquired a lipid-filled
phenotype resembling brown/beige adipocytes (Fig 4D). Gene
expression analysis demonstrated a progressive decrease in
myogenic transcripts in PPARc-overexpressing cells over time,
which concurred with a strong upregulation of terminally differenti-
ated adipocyte markers, including FABP4 and ADIPOQ at day 21
(Fig 4G). PPARc overexpression also induced robust activation of
genes specific for brown/beige fat, such as UCP1 and ELOVL3
(Fig 4G), suggesting a brown/beige fat identity of the switched cells.
Intriguingly, when NLS-WT1 was co-overexpressed with PPARc—
conditions more closely resembling the situation seen in PKP2
mutant CMs—we observed an acceleration of the myocyte-to-adipo-
cyte conversion process, as indicated by the faster appearance of
lipid-filled adipocyte-like cells (Fig 4E). At the mRNA level, we
measured a higher upregulation of FABP4 and ADIPOQ in
NLS-WT1/PPARc-overexpressing cells compared to PPARc overex-
pression alone throughout the 3-week culture period (Fig 4H).
Interestingly, PPARc expression was likewise significantly
elevated in the NLS-WT1/PPARc condition (Fig 4H), indicating a
possible PPARc-dependent regulation of endogenous PPARc by
WT1.
To further investigate the potential cooperative role of WT1 and
PPARc in the cardiomyocyte-to-adipocyte switch, we first tested
whether knockdown of endogenous WT1 in PPARc-overexpressing
wt CMs would negatively affect their conversion. Indeed, by day 21,
cultures expressing shRNA targeting WT1 showed a striking reduc-
tion in lipid-filled adipocyte-like cells and levels of adipocytic genes
(Fig 4F and H), while scrambled shRNA had no effects
(Appendix Fig S6). Co-immunoprecipitation analysis in NLS-WT1/
PPARc-overexpressing wt CMs ultimately demonstrated a physical
interaction of the two proteins in the nucleus of converting cells
(Fig 4I). Finally, we evaluated the effects of NLS-WT1 and PPARc
overexpression in adult mouse CMs that lack endogenous Wt1.
Using adeno-associated virus-mediated delivery of the transgenes in
Myh6Cre/+;R26mTmG/+ mice, we observed emergence of intramyo-
cardial lipid-filled/Plin+ adipocyte-like cells labeled by mG exclu-
sively in hearts of animals that received both viruses (Fig EV5).
Altogether, these findings identify PPARc as the master
molecular trigger of the cardiomyocyte-to-brown/beige fat switch
and demonstrate the requirement of WT1 for the conversion
process.
RhoA signaling downstream of cell–cell junctions regulates
pathological myocyte-to-adipocyte conversion by controlling
MRTF-A cellular localization and PPARc activation
In order to uncover the molecular mechanisms linking defective
cell–cell contacts to changes of transcriptional programs predispos-
ing to pathological myocyte-to-adipocyte conversion, we compared
the genome expression profiles of PKP2 mutant and wt CMs (Fig 5).
In mutated CMs, Gene Set Enrichment Analysis (GSEA) identified
significant overrepresentation of gene categories related to cell–cell
and cell–matrix communication and adhesion as well as extracellu-
lar matrix remodeling (Fig 5A). Enrichment in gene sets associated
with increased adipogenesis, including “adipogenesis by activated
PPARc”, “classic adipogenic targets of PPARc”, and “adipogenesis
early up”, was likewise detected (Fig 5A and B). Since profiled cells
were CMs before induction of the adipocyte switch, upregulation of
the adipogenic program controlled by PPARc was likely due to fail-
ure in PPARc gene silencing in presence of the PKP2 mutation.
PPARc was indeed slightly upregulated (1.7-fold) in mutant CMs
(Fig 5B), as shown by qRT–PCR at baseline (Fig 1F). Concordantly,
analysis of histone marks of active (H3K4me3) and repressed
(H3K27me3) promoters as well as active enhancers (H3K27ac) at
the PPARc locus by chromatin immunoprecipitation demonstrated
significant lower levels of H3K27me3 and higher H3K4me3 and
H3K27ac occupancy in mutated CMs (Fig 5C).
Remarkably, in PKP2 mutants, GSEA also revealed increased
expression of genes typically upregulated in cells experiencing inhi-
bition of the RhoA-GTPase/Rho-associated protein kinase (ROCK)
pathway and undergoing cytoskeleton rearrangement (Fig 5A and
D). Moreover, we found that genes known to be targets of the serum
response factor (SRF) and its coregulator myocardin-related tran-
scription factor (MRTF; Esnault et al, 2014) were likewise signifi-
cantly over-represented in mutated cells (Fig 5E). These results
were quite intriguing in light of recent evidence indicating that
suppression of RhoA/ROCK signaling induces adipocyte differentia-
tion and specifically brown/beige adipocyte formation via control of
G-actin-regulated MRTF-A (Nobusue et al, 2014; McDonald et al,
2015). RhoA signaling mediates the dynamic control of monomeric
and filamentous cytoskeleton actin (Sotiropoulos et al, 1999;
Tominaga et al, 2000; Geneste et al, 2002). Monomeric G-actin can
regulate the nucleus–cytoplasm shuttling of MRTF and, thereby,
influence the expression of MRTF/SRF target genes (Miralles et al,
2003; Olson & Nordheim, 2010), which are required for muscle
formation and identity (Balza & Misra, 2006; Mokalled et al, 2015),
as well as PPARc expression (Nobusue et al, 2014).
Since activated GTP-bound RhoA localizes at the intercellular
interfaces after cell–cell contacts (Watanabe et al, 2009; Godsel
et al, 2010), thus linking cell–cell adhesion to cytoskeleton remodel-
ing and gene regulation, it appeared a strong candidate in triggering
the morphological and transcriptional changes during myocyte-to-
adipocyte conversion in presence of defective cell–cell contacts. We
began addressing this possibility by comparing RhoA localization
and the level of RhoA activity as well as cytoskeleton actin
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organization in wt and PKP2 mutated CMs (Fig 6). Immuno-
cytochemistry revealed a decreased concentration of RhoA at the
plasmamembrane of mutant CMs at baseline (Fig 6A), which
associated with a significant reduction in RhoA activity, assessed
by ELISA as ratio “active RhoA-GTP/total RhoA” (Fig 6B). RhoA
activity further declined after 24 h of culture in lipogenic milieu
exclusively in PKP2 mutants (Fig 6B), suggesting a higher respon-
siveness of these cells to the pro-adipogenic condition. Moreover,
coincident with a reduction in RhoA activity, we observed an
increase in monomeric G-actin levels in mutated CMs during the
early phase of myocyte-to-adipocyte conversion, when the first
signs of disruption of cytosolic actin microfilaments (marked by
Phalloidin) were visible (Fig 6C).
We next explored whether MRTF-A localization is also altered in
CMs with defective cell–cell adhesion. Monomeric G-actin binds to
MRTF-A and prevents it from translocating to the nucleus and regu-
lating transcription. Initial immunohistochemistry analysis of
endogenous MRTF-A in wt and PKP2 mutated CMs before and
during myocyte-to-adipocyte conversion revealed a pancellular (cy-
toplasmic and nuclear) localization and no clear differences
between the groups (Appendix Fig S7A), suggesting a dynamic shut-
tling process. In order to monitor dynamic changes in MRTF-A
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Figure 5. Transcriptome and histonemark analyses reveal aberrant regulation of adipogenesis and impaired RhoA- andMRTF/SRF-dependent gene programs
in PKP2mut CMs.
A Functional annotation of genome-wide differentially expressed genes in PKP2mut CMs with gene set enrichment analysis (GSEA).
B GSEA of gene sets for adipogenesis (left). For each GSEA, the normalized enrichment score (NES) and P-value are specified. Relative expression of the “leading edge”
genes of the three adipogenic GSEAs is shown in heatmaps on the right. Expression level is represented as a gradient from low (blue) to high (red).
C Genome browser representation for H3K4me3, H3K27me3, and H3K27ac tracks at the PPARc locus in wt CMs identified by ChIP-Seq (top). qPCR analyses of
H3K4me3-, H3K27me3-, and H3K27ac-ChIP on p1 and p2 peaks (shaded in gray) at the PPARc locus in wt and PKP2mut CMs and human adipocytes (bottom); n = 2;
*P < 0.05 vs. wt; t-test.
D, E Plots of the BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP (D) and SRF_C and SRF_01 (E) GSEAs. NES and P-value are shown. Relative expression of the
“leading edge” genes of the GSEA is shown in the concomitant heatmaps. Direct MRTF-SRF downstream target genes are highlighted in blue. Expression level is
represented as a gradient from low (blue) to high (red).
Source data are available online for this figure.
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Figure 6. Decreased RhoA signaling downstream of defective cell–cell contacts leads to reduced nuclear MRTF-A localization and derepression of PPARc.
A Immunostaining of cTNT (cyan), PKP2 (red), and RhoA (green) in wt and PKP2mut CMs. Scale bars, 12.5 lm.
B RhoA activity in wt and PKP2mut CMs at 0 and 1 day in culture; n = 3; *P < 0.05, **P < 0.001 vs. wt at the same time point; t-test.
C Immunostaining of F-actin (Phalloidin, green) and actin (red) in wt and PKP2mut CMs at 0 and 7 days in culture. Scale bars, 12.5 lm. Bar graph shows
quantification of G-actin/F-actin ratio in wt and PKP2mut CMs; N = 10 (wt) and N = 9 (PKP2mut) cells; *P < 0.01 vs. wt at the same time point; Mann–Whitney U-
test.
D, E Live imaging of MRTF-A subcellular localization in wt and PKP2mut CMs by transient expression of doxycycline-inducible MRTF-A-GFP. Images in (D) show
representative CMs at d0 in 20% serum (left) and after subsequent treatment with adipogenic medium for 1 h (middle). Images in (E) show representative CMs in
adipogenic medium at 7 days, before (left) and after treatment with 20 nM LMB for 1 h (middle). Small panels on the right show magnified views of the boxed
areas. Arrows indicate dynamic changes of nuclear MRTF-A localization before and after corresponding treatment. Scale bars, 50 lm (left and middle panels) and
25 lm (right panels). Bar graphs show average values of nuclear/cytoplasmic ratio of GFP signal intensity in wt and PKP2mut CMs at indicated conditions; (D):
N = 60 (wt) and N = 37 (PKP2mut) cells; (E): N = 105 (wt) and N = 64 (PKP2mut) cells; *P < 0.001 vs. wt at the same condition; Mann–Whitney U-test.
F Immunostaining of cTNT (magenta), GFP (green), and PPARc (red) in wt and PKP2mut CMs infected with MRTF-A-GFP and cultured in adipogenic medium for 7 days.
Cells were treated as in (E) before fixation. Arrows indicate differential PPARc expression dependent on levels of nuclear MRTF localization. Scale bars, 25 lm.
G Prevention of myocyte-to-adipocyte conversion in PKP2mut CMs by continuous overexpression of MRTF-A-GFP. Immunostaining of GFP (green) and correspondent
colorimetric immunodetection of cTNT (blue) in conjunction with lipid stain ORO (top) and cTNT (magenta), GFP (green), and PPARc (red) (bottom) in PKP2mut CMs
overexpressing MRTF-A-GFP cultured in adipogenic medium for 28 days. Phase-contrast image is merged with PPARc and GFP. Scale bars, 50 lm (top), 12.5 lm
(bottom). Dotted lines indicate the border separating GFP+ and GFP (left) as well as ORO+ and ORO (right) cells. Adjacent bar graphs indicate the percentage of
adipocyte-like cells (top) or PPARc+ cells (bottom) that were positive and negative for GFP; n = 3; N = 840 cells (top graph) and N = 306 cells (bottom graph);
*P < 0.001 vs. GFP; t-test.
Data information: All data are shown as means  SEM.
Source data are available online for this figure.
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localization in the same cell over time, we transiently expressed a
doxycycline-inducible MRTF-A-GFP fused protein and treated the
cells with high serum-containing medium for 30 min to induce
MRTF-A nuclear translocation (Fig 6D). Shortly after switching to
pro-adipogenic culture condition (1 h), PKP2 mutants exhibited a
clear reduction in nuclear GFP signal, which was conversely main-
tained in wt cells (Fig. 6D), suggesting a decreased nuclear shuttling
of MRTF-A in mutant CMs at baseline. This was additionally con-
firmed at the early stage of myocyte-to-adipocyte conversion by
blocking MRTF-A nuclear export with leptomycin B (LMB), which
revealed a reduced nuclear MRTF-A accumulation in mutated cells
at day 7 (Fig 6E). Beginning of PPARc upregulation was detected in
those cells showing the highest ratio of cytoplasmic/nuclear GFP
signal (Fig 6F), suggesting that cytoplasmic sequestration of MRTF-
A due to enhanced G-actin levels in PKP2 mutant CMs could be
responsible for the pathological myocyte-to-adipocyte switch by
regulating PPARc expression.
To further test whether MRTF-A localization ultimately controls
PPARc activation and thus myocyte-to-adipocyte conversion in pres-
ence of defective cell–cell contacts, we permanently applied doxycy-
cline in the pro-adipogenic medium to induce a continuous
overexpression of MRTF-A-GFP and hence a relative surplus of
MRTF-A in the nucleus (Appendix Fig S7B). We then examined
whether this molecular intervention could rescue or ameliorate the
adipogenic switch of PKP2 mutated CMs and influence PPARc
expression. Staining of cTNT in conjunction with ORO at 28-day
culture demonstrated acquisition of the adipogenic phenotype exclu-
sively in mutant cells lacking GFP expression, while failure to
undergo adipocyte conversion was observed in the MRTF-A-GFP-
overexpressing counterparts (Fig 6G). Moreover, in the latter we did
not detect any PPARc activation (Fig 6G), indicating a key role of
MRTF-A dynamics and nuclear levels in determining the conversion
process by modulating PPARc expression.
Repression of RhoA/ROCK signaling in wt CMs simulates
pathological myocyte-to-adipocyte switch caused by defective
cell–cell adhesion
Based on the evidence that the myocyte-to-adipocyte conversion in
the presence of defective cell–cell contacts was associated with a
reduction in RhoA activity, we hypothesized that pharmacological
inhibition of ROCK—as the major effector of the RhoA pathway
(Schofield & Bernard, 2013)—may mimic the effect of genetically
impaired cell–cell adhesion. To test this, we treated wt CMs with the
ROCK inhibitor Y-27632, while cells were exposed to pro-adipogenic
culture conditions. Remarkably, after only 14-day treatment, disrup-
tion of cell–cell junctions was evident in the majority of CMs, as
illustrated by weaker and interrupted plakophillin expression at the
plasmamembrane (Fig 7A), suggesting a positive feedback regula-
tion of RhoA/ROCK signaling on cell–cell contact stability. Further-
more, exposure to Y-27632 for 28 days induced a severe remodeling
of the actin cytoskeleton with nuclear shuttling of WT1 and activa-
tion of PPARc expression (Fig 7B), which ultimately correlated with
the appearance of few lipid-filled adipocyte-like cells, as shown by
ORO staining (Fig 7C). Although the efficacy of this pharmacologi-
cal approach appeared low, the overall ability of some CMs to
convert into adipocytes upon ROCK inhibition indicates a critical
function of RhoA/ROCK signaling in integrating cell–cell junctional
structures with cytoskeletal organization to influence localization
and activation of proteins that control transcriptional programs
affecting CM state. Moreover, it reinforces the hypothesis that
subsets of CMs exist, which are permissive to undergo adipocyte
conversion more readily than others, possibly due to a shared
common developmental origin with cardiac adipocytes.
Genetic perturbation of RhoA-mediated cytoskeleton remodeling
induces myocyte-to-adipocyte switch
To further verify the importance of RhoA/ROCK-dependent cytoskele-
ton remodeling in driving pathological myocyte-to-adipocyte switch,
we analyzed whole-exome sequencing data from ARVC patients
lacking mutations in classical disease-causing genes. We reasoned
that if this mechano-signaling is relevant in ARVC, then genes
belonging to the RhoA/cytoskeletal pathway may be targets of
pathogenic mutations. Strikingly, in one of four cases we identified
a heterozygous nonsense mutation (c.1729C>T; p.R577*) in
MYH10. This gene encodes the non-muscle myosin IIB (NMIIB) of
the actomyosin cytoskeleton, which has been reported to regulate
both actin dynamics (Rex et al, 2010) and accumulation of
active RhoA-GTP at the adherens junctions (Priya et al, 2015).
Remarkably, among all genes that have been associated with ARVC,
MYH10 showed the maximum value of 1 for the ExAC index pLI
(which indicates the probability that a gene is intolerant to a loss-of-
function mutation—see Materials and Methods and Appendix
Table S1), suggesting a high likelihood for the novel R577*-MYH10
mutation to be disease causing. We generated iPSCs harboring the
R577*-MYH10 mutation (Appendix Fig S8A–G) and examined the
phenotype of the derived CMs before and after exposure to
lipogenic milieu (Fig 7D–J). Western blot analyses revealed a ~50%
reduction in NMIIB protein, while transcript levels were unchanged
(Appendix Fig S8H and I). Already at baseline, a reduced accumula-
tion of NMIIB at the cell–cell junctions was evident in MYH10
mutated CMs and correlated with a decreased plasmamembrane
concentration of RhoA (Fig 7D and E). Interestingly, compromised
cell–cell adhesion was also discernable (Fig 7E and Appendix Fig
S8J). These changes associated with elevated levels of cytosolic
G-actin and impaired nuclear shuttling of MRTF-A (Fig 7F and G).
Moreover, we measured a basal increase in PPARc and PRDM16
transcripts, which further progressively augmented during culture
in lipogenic milieu (Fig 7H). Similarly to CMs with defective PKP2
levels, a subset of MYH10 mutants exhibited nuclear translocation
of WT1 and activation of PPARc when cultured in pro-adipogenic
conditions (Fig 7I) and ultimately converted into adipocytes
(Fig 7J).
Together, these findings indicate an unprecedented function of
NMIIB as canonical RhoA effector in regulating CM identity and
support the pivotal role of RhoA signaling in triggering cardio-
myocyte-to-brown/beige adipocyte conversion in response to adipo-
genesis-inducing cues.
Discussion
While it is widely accepted that mechanical cues contribute to cell
fate decisions during differentiation of stem cells (McBeath et al,
2004), little is known about how mechanical inputs at cell–cell or
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Figure 7. Pharmacological and genetic perturbation of RhoA-mediated cytoskeleton remodeling induces myocyte–adipocyte conversion.
A, B Immunostaining of F-actin (Phalloidin, green) and PKP2 (red) in wt CMs treated and non-treated with 30 lM ROCK inhibitor Y-27632 for 14 days (A).
Immunofluorescence analysis of WT1 (magenta), F-actin (Phalloidin, green), and PPARc (red) in wt CMs treated and non-treated with 30 lM Y-27632 for 28 days.
Arrow indicates a cell with severe remodeling of the actin cytoskeleton, nuclear shuttling of WT1, and PPARc expression (B). Scale bars, 25 lm.
C Immunodetection of cTNT (blue) and lipid stain ORO (red) in wt CMs untreated and treated with 30 lM Y-27632 for 28 days. Scale bars, 50 lm. Bar graph shows
the percentage of adipocyte-like cells in treated and untreated conditions; n = 3; N = 600 (untreated) and N = 592 (Y-27632) cells; *P < 0.05 vs. untreated cells; t-
test.
D, E Immunostaining of cTNT (green) and NMIIB (red) (D) or cTNT (cyan), PKP2 (red), and RhoA (green) (E) in wt and MYH10mut CMs. Scale bars, 12.5 lm.
F Immunostaining of F-actin (Phalloidin, green) and actin (red) and quantification of G-actin/F-actin ratio in wt and MYH10mut CMs. Scale bars, 12.5 lm. N = 11 (wt)
and N = 13 (MYH10mut) cells; *P < 0.05 vs. wt; Mann–Whitney U-test.
G Live imaging of MRTF-A subcellular localization in wt and MYH10mut CMs by transient expression of doxycycline-inducible MRTF-A-GFP. Shown are representative
myocytes at d0 in 20% serum (left) and after subsequent treatment with adipogenic medium for 1 h (middle). Small right panels show magnified views of the
boxed areas. Arrows indicate dynamical changes of nuclear MRTF-A localization. Scale bars, 50 lm (left and middle) and 25 lm (right). Bar graph presents
quantification of nuclear/cytoplasmic ratio of GFP signal intensity in wt and MYH10mut CMs; N = 55 (wt) and N = 53 (MYH10mut) cells; *P < 0.001 vs. wt; Mann–
Whitney U-test.
H qRT–PCR analysis of myocytic and adipocytic genes in wt and MYH10mut CMs over time in culture; n = 3; *P < 0.05, **P < 0.01 vs. wt at the same time point; t-test.
I Immunostaining of F-actin (Phalloidin, green), WT1 (magenta), and PPARc (red) in wt and MYH10mut CMs at 28 days of culture. Arrows indicate cells with severe
remodeling of the actin cytoskeleton, nuclear WT1, and PPARc expression. Scale bars, 25 lm.
J Colorimetric immunodetection of cTNT (blue) and lipid stain ORO (red) in wt and MYH10mut CMs at 28 days of culture. Scale bars, 50 lm. Bar graph shows the
percentage of adipocyte-like cells in wt and MYH10mut conditions; n = 3; N = 567 (wt) and N = 520 (MYH10mut) cells; *P < 0.05 vs. wt (t-test).
Data information: All data are shown as means  SEM.
Source data are available online for this figure.
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cell–matrix adhesions translate into intracellular signals to maintain
cell identity or direct fate switch. Here we describe an adhesion-
linked signaling and transcriptional regulatory pathway that medi-
ates myocyte-to-adipocyte lineage conversion (Fig 8), thereby
providing a mechanism by which mechanical signals through cell–
cell contacts integrate with soluble cues and translate into a change
in cell fate. Using human iPSCs with defective cell–cell adhesion
due to a PKP2 frameshift mutation or impaired RhoA signaling
caused by a nonsense MYH10 mutation, we show that cell–cell
contact-mediated mechanosensing plays a pivotal role in controlling
CM identity through a series of interwoven, reinforcing pathways
that converge on the engagement of a RhoA/MRTF/SRF-signaling
circuit. When impaired, CMs become primed to switch to brown/
beige adipocytes in response to adipogenesis-inducing signals acting
on this circuit. Moreover, by tracking the fate of murine cardiovas-
cular progenitors expressing Isl1 and Wt1, we provide evidence for
an intimate developmental relationship between CMs and AV
groove adipocytes. Accordingly, we demonstrate that a single Isl1+/
Wt1+ progenitor can give rise to both CMs and fat cells in vitro,
which ultimately suggests related mechanisms of determination
between the two lineages.
Our data show that in human developing CMs cell–cell contacts
at the intercalated disk connect to remodeling of the actin cytoskele-
ton by regulating RhoA-ROCK signaling to maintain an active
MRTF/SRF transcriptional program. By controlling expression of
muscle-specific and adipogenesis-related genes as well as cytoskele-
ton, intercellular junction, and extracellular matrix genes, MRTF/
SRF sustains cardiac muscle identity and function, while inhibiting
adipogenic commitment (Fig 8). Reduction in RhoA-ROCK signaling
initiated by defects in cell–cell adhesion poises CMs to convert to
adipocytes in response to external adipogenesis-inducing cues,
which act as feed-forward mechanism by further downregulating
the RhoA-MRTF/SRF pathway. Indeed, standard pro-adipogenic
cocktails, such as the one used in this study, contain IBMX,
dexamethasone, and insulin. Both IBMX and dexamethasone
inhibit RhoA/ROCK activity by activating protein kinase A
(Petersen et al, 2008). The fact that a lipogenic milieu provoked
cardiomyocyte-to-adipocyte conversion only in cells with
impaired cell–cell junctions or RhoA signaling and that additional
ROCK inhibition was necessary to trigger the cell fate change in
wt CMs indicates that, in absence of a permissive environment,
such as altered mechanosensing, this feed-forward mechanism
does not become activated. Moreover, 4-week treatment with the
ROCK inhibitor Y-27632 resulted in cardiomyocyte-to-adipocyte
switch in a limited number of wt cells, suggesting that only some
CMs are primed for this cell fate switch, presumably because of
permissive transcriptional or epigenetic states acquired during
development. In line with this, it has recently been shown that
ROCK inhibition in the developing heart, but not after birth, leads
to fibrofatty replacement of CMs in the RV of adult mice, which is
associated with markedly disorganized myocardial structures and
cell–cell junctions, as well as increased PPARc levels, pointing
toward adipogenic phenotypic changes (Ellawindy et al, 2015).
Moreover, our results, indicating that a subset of cardiac muscle
and epicardial fat cells share a common developmental origin and
that CMs differentiated from mESC-derived Isl1+/Wt1+ clones are
highly responsive to adipogenic stimuli, suggest that CMs emerg-
ing from Isl1+/Wt1+ progenitors could be those more prone to a
myocyte-to-adipocyte switch when exposed to adipogenesis-indu-
cing cues, though this remains to be examined in vivo.
While MRTF/SRF signaling has been shown to be essential for
CM differentiation and function (Niu et al, 2005; Parlakian et al,
2005; Mokalled et al, 2015) and to inhibit differentiation of preadi-
pocytes and multipotent mesenchymal progenitor cells into
adipocytes (Mikkelsen et al, 2010; Nobusue et al, 2014; McDonald
et al, 2015), no evidence existed for a role in controlling cell fate
switch between these two mesodermal lineages. Our work demon-
strates that overexpression of MRTF-A in human PKP2 mutated CMs
prevents their conversion into adipocytes in response to adipogene-
sis-inducing signals by hindering PPARc activation. Thus, it will be
important to investigate whether it can be used therapeutically in
ARVC. Interestingly, it has been reported that RhoA-GTPase is an
essential modulator of insulin-like growth factor 1 (IGF1) signals that
direct the adipogenesis–myogenesis cell fate decision of common
mesenchymal precursors in vivo and in vitro (Sordella et al, 2003).
Whether RhoA activity controls adipogenesis–myogenesis decision
through involvement of MRTF/SRF has not been examined, however.
Recent evidence suggests that IGF1R signaling also governs
epicardial adipose tissue formation in the context of myocardial
injury in mice by redirecting the fate of Wt1+ lineage cells (Zangi
et al, 2017). Wt1 expression seems to be required for such process
(Zangi et al, 2017). It is relevant to mention that, differently from
humans, the mouse heart has very little fat during homeostasis and
only upon injury does some degree of relaxation in the negative
control of adipogenesis occur (Liu et al, 2014; Yamaguchi et al,
2015). Interestingly, Wt1 expression is restricted only to cells of the
epicardium, the outer mesothelial layer of the heart, and completely
absent in CMs (Zhou et al, 2008). Our immunocytochemical and
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Figure 8. Model describing cell–cell adhesion-dependent regulation of
cardiomyocyte-to-adipocyte lineage conversion.
Impaired intercellular contacts at the intercalated disk of developing cardiac
myocytes lead to a reduction in RhoA-GTPase activity and remodeling of actin
cytoskeleton resulting in increased level of cytosolic G-actin. G-actin binding to
MRTF prevents its nuclear translocation, resulting in repression of the MRTF/
SRF-regulated myogenic lineage commitment and activation of the alternative
adipocytic gene program triggered by PPARc.
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immunohistochemical analyses of human iPSC-derived CMs and
adult human heart tissue indicate that high levels of WT1 are
normally detectable in the cytoplasm of human cardiac muscle, con-
firming previous studies in developing human hearts (Ambu et al,
2015). Remarkably, we observed a nuclear translocation of WT1
protein occurring during the early phase of cardiomyocyte-to-adipo-
cyte conversion in PKP2 and MYH10 mutant cells as well as wt CMs
treated with the ROCK inhibitor Y-27632, suggesting an involvement
of cell contact-mediated RhoA signaling in resolving activation of
WT1 as a transcription factor in these cells. Further studies will be
needed to address the precise mechanism by which RhoA/ROCK
pathway controls WT1 subcellular localization. Furthermore, our
overexpression and loss-of-function studies in wt human iPSC-CMs
and in adult CMs of Myh6Cre/+;R26mTmG/+ mice indicate that WT1,
although not sufficient to provoke the myocyte-to-adipocyte switch,
is essential for the conversion process induced by PPARc. Addition-
ally, we measured a physical co-interaction of WT1 and PPARc in
the nucleus of myocyte–adipocyte converting cells, suggestive of a
cooperative role of the two transcription factors in regulating the
adipogenic program.
Our expression profiling results and histone modification analy-
sis of the PPARc locus indicate an aberrant ectopic activation of
PPARc and the adipocytic program in PKP2 mutant CMs before any
exposure to adipogenesis-inducing signals. This finding, together
with the fact that only a fraction of mutated CMs could convert to
adipocytes in our experimental conditions, supports the concept that
faulty mechanical sensing due to defects in cell–cell contact may
prevent adipogenic gene silencing and faithful cardiomyocytic
commitment of a bipotent myo-adipo progenitor cell during cardio-
genesis. As result, the differentiated CM progeny will be permissive
to switch to the alternative adipocytic fate when exposed to appro-
priate stimuli.
In agreement with our work, previous studies have reported
exaggerated lipogenesis and abnormal PPARc activation in iPSC-
derived CMs from ARVC patients carrying PKP2 mutations when
exposed to adipogenesis-inducing cues (Caspi et al, 2013; Kim et al,
2013; Ma et al, 2013). However, a stable lineage switch of CMs to
adipocytes was not resolved in these studies. By applying culture
settings that mimic the mechanical strain of the adult heart, we
provide the first evidence of a direct lineage conversion that natu-
rally occurs under pathological conditions in human cells.
Taken together, we have identified a cell–cell contact-driven
transcriptional rheostat that controls human CM identity and when
impaired predisposes CMs to convert into brown/beige adipocytes
in response to adipogenesis-inducing soluble cues. This study sheds
important light on how cell–cell junctional architecture, cytoskele-
ton organization, and transcriptional regulation are coupled to regu-
late cellular identity. Thus, it provides novel insights on how
mechanical signals in CMs can control cell fate switch by feeding
into the regulation of core pathways.
Materials and Methods
Generation, culture, and in vitro differentiation of human iPSCs
Dermal keratinocytes from PKP2mut and MYH10mut ARVC patients
and healthy controls were isolated as previously described (Aasen
et al, 2008) and reprogrammed into iPSCs using Sendai viruses
coding for OCT4, SOX2, KLF4, and c-MYC. All recruitment and
consenting procedures were done under institutional review board-
approved protocols of both the Klinikum rechts der Isar, Technical
University of Munich, and the Addenbrooke’s and Papworth Hospi-
tals, Cambridge University Health Partners. Written informed
consent was obtained from affected patients and healthy volunteers.
Spontaneous differentiation of iPSCs into cells of all three germ
layers was induced by embryoid body (EB) formation, as previously
reported (Moretti et al, 2010). Neural differentiation was achieved
by growing EBs in suspension for the first 7 days and then as adher-
ent EBs on laminin-coated dishes for further 2 weeks.
iPSC-derived CMs were obtained using PSC Cardiomyocyte Dif-
ferentiation Kit (Life Technologies). Two- to three-month-old CM
cultures were dissociated into single cells using 480 U/ml collage-
nase type II (Worthington) and purified with PSC-derived Cardio-
myocyte Isolation Kit, human (Miltenyi). CM purity assessed by
flow cytometry reached 97%. Single CMs were then plated on fibro-
nectin-coated 50-kPa dishes (Matrigen) as monolayer, subjected to
1 Hz electrical pacing, thus imitating the laminar sheet-like architec-
ture, the stiffness, and the beating-induced cellular tension of the
adult heart tissue. Treatment with adipogenic medium (Lonza)
containing insulin, dexamethasone, indomethacin, and IBMX was
initiated 3 days later. Samples were collected at d0, d14, d28, and
8 weeks in culture in adipogenic medium for immunohistochemical
and molecular biological analysis. All experiments were performed
using two clones for each iPSC line. Wild-type cells were obtained
from three independent control iPSC lines from three unrelated
healthy individuals.
Human iPSC-derived brown/beige adipocytes were differentiated
as previously described (Guenantin et al, 2017).
Teratoma formation
Six-week-old severe combined immunodeficient (SCID) mice
(Charles River Laboratories) were anesthetized, and ~1 million
iPSCs were inoculated beneath the kidney capsule. Teratomas were
harvested 6 weeks post-injection, paraffin embedded, and stained
with hematoxylin and eosin for the histological determinations.
Exome sequencing, genomic sequencing, and karyotype analysis
Genomic DNA was isolated using Genomic DNA Purification Kit
(Gentra Systems). Direct sequencing of the five potentially causative
desmosomal genes (PKP2, DSP, JUP, DSG2, and DSC2) was
performed at the UCL Centre for Inherited Cardiovascular Disease
with coverage of all exons as well as flanking intronic regions and
revealed the previously described heterozygous frameshift mutation
(c.1760delT; p.V587Afs*655) in PKP2 (Te Riele et al, 2013) in one
patient. For exome sequencing, SureSelect Human All Exon 50 Mb
kit (Agilent) was applied for in-solution enrichment of exonic regions
followed by sequencing as 100 base-pair (bp) paired-end runs on a
HiSeq2500 (Illumina). Reads were aligned to the human genome
assembly hg19 (UCSC Genome Browser) with Burrows-Wheeler
Aligner (BWA, v.0.5.87.5), and detection of genetic variation was
performed using SAMtools (v0.1.18), PINDEL (v0.2.4t), and Exome-
Depth (v1.0.0). Variant annotation was performed applying custom
Perl scripts, including information about known transcripts (UCSC
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genes and RefSeq genes), known variants (dbSNP v135), type of
mutation, and amino acid change (where applicable). The obtained
variants were then inserted into the Helmholtz Zentrum Mu¨nchen
database, including 10,900 exomes. All synonymous and intronic
(other than canonical splice sites) variants were excluded, and qual-
ity control filters were applied as well (variant quality ≥30 and
mapping quality ≥50). Genetic variants were interrogated in the 1000
Genomes project (www.1000genomes.org) and the Exome Aggrega-
tion Consortium (ExAC) browsers (http://exac.broadinstitute.org)
and Sanger validated. Predicted functional effect of a coding variant
was surveyed using Polyphen2 (http://genetics.bwh.harvard.edu/
pph/), SIFT (http://sift.jcvi.org/), and Combined Annotation Depen-
dent Depletion (CADD; http://cadd.gs.washington.edu/). Exome
sequencing yielded 13 Gb of mappable sequences, and 98% of the
targeted sequences were covered at least 20-fold with a mean cover-
age of at least 139×. Bioinformatics filtering of variants was based on
recessive and dominant inheritance patterns. Prioritization of reces-
sive protein-altering variants with a minor allele frequency 0.001%
in the Exome Aggregation Consortium (ExAC) Browser (v.0.3.1) or
an internal database containing 10,900 control exomes identified 18
bi-allelic variants that were considered unlikely to be causative for
the observed ARVC phenotype. Considering a dominant effect, the
index subject’s WES data were quested for protein-altering sequence
variations with a minor allele frequency 0.0001% in the ExAC
Browser or in the internal database. Among 211 heterozygous vari-
ants, a phenotype-based search identified nonsense variant in
MYH10 (c.1729C>T, p.R577*). The variant was not present among
10,900 internal exomes and 60,706 exomes in the ExAC database.
The probability of loss-of-function intolerance (pLI) in ExAC browser
reaches the maximum value. The amino acid change involves a
highly conserved amino acid residue (CADD score 38).
Genotype of the patient iPSCs was confirmed by sequencing
(Eurofins MWG Operon) on genomic DNA from iPSCs with primers
corresponding to the mutated region located in exon 8 of the PKP2
gene or exon 15 of the MYH10 gene. Primer sequences are provided
in Appendix Table S2.
Karyotyping of the iPSC lines was performed at the Institute of
Human Genetics of the Technical University of Munich using stan-
dard methodology.
Generation, culture, and differentiation of mouse ESCs
Isl1Cre/+;R26YFP/+ mouse line was used to isolate ESCs as previ-
ously described (Nichols et al, 2009). ESCs were maintained in
mESC medium and differentiated in EBs as previously reported
(Moretti et al, 2006). Single cells were dissociated from 4-day-old
EBs and sorted for YFP expression using flow cytometry. YFP+
cardiac progenitors were either differentiated into adipocytic and
cardiomyocytic lineage or plated on mitomycin C-treated cardiac
mesenchymal feeder cells (CMC) for clonal expansion. For
adipogenic differentiation, cells were plated in mESC medium
supplemented with 5 lM insulin (Sigma-Aldrich) and 0.1 lM
dexamethasone (Sigma-Aldrich) [mESC + 2F] on 0.1% gelatin-
coated plates and cultured for 4 weeks. For myogenic differentia-
tion, cells were reaggregated in mESC medium and collected for
analysis 6 days later. Progenitors seeded for clonal experiments
were cultured for 6 days on CMCs, and the resulting clones were
dissociated into single cells and then divided into three parts.
One part was differentiated in adipogenic conditions as decribed
above. The second part was differentiated in myogenic conditions
(Moretti et al, 2006). The third part was used for RT–PCR
analysis.
Reverse transcription PCR (RT–PCR) and quantitative real-time
PCR (qRT–PCR)
Total mRNA was isolated from keratinocytes, iPSCs, CMs, iPSC-
derived brown/beige adipocytes, and cardiac progenitors using the
Stratagene Absolutely RNA kit, and 1 lg was used to synthesize
cDNA with the High-Capacity cDNA Reverse Transcription kit
(Applied Biosystems). Gene expression was quantified by qRT–PCR
using 1 ll of the RT reaction and the Power SYBR Green PCR Master
Mix or Taqman assays (Applied Biosystems). Gene expression levels
were normalized to GAPDH. A list of the primers and Taqman
probes is provided in Appendix Table S2.
Genome-wide transcriptional profiling and Gene Set
Enrichment Analysis—GSEA
Microarray expression profiling was performed on pooled mRNA
isolated from iPSC-derived CMs obtained from three independent
differentiation experiments. The GeneChip microarray processing
was performed by IMGM Laboratories (Munich) according to the
manufacturer’s protocols. The amplification and labeling were
processed with 100 ng starting RNA. For each sample, 600 ng
single-stranded DNA was labeled and hybridized to the SurePrint
G3 Human GE Microarray chips. Fluorescent signal intensities were
detected with Scan Control A.8.4.1 software (Agilent Technologies)
on the Agilent DNA Microarray Scanner and extracted by the
Feature Extraction 10.7.3.1 software (Agilent Technologies). The
software tools Feature Extraction 10.7.3.1, GeneSpring GX 11.5.1
(Agilent Technologies), and Spotfire Decision Site 9.1.2 (TIBCO)
were used for quality control and statistical analysis. Agilent Sure-
Print G3 Human GE Microarrays (8 × 60 K) raw intensity data were
imported in R statistical environment using limma package (Ritchie
et al, 2015) for background subtraction, quantile normalization, and
log2 transformation of the signal values. Linear modeling approach,
empirical Bayes statistics with Benjamini and Hochberg multiple
testing correction was utilized to obtain genes whose fold change
between comparisons was > 1.5 with a P value cutoff of < 0.05.
Gene Set Enrichment Analysis was performed using GSEA
(Subramanian et al, 2005; 1.000 permutations; genes ranked accord-
ing to PKP2mut vs. wt log P-value * sign FC).
Chromatin Immunoprecipitation Sequencing (ChIP-Seq) and
data processing
3 × 104 2-month-old WT, PKP2mut CMs, and in vitro differentiated
human adipocytes (Lonza) were cross-linked for 15 min in 1%
formaldehyde (Thermo Scientific). The reaction was stopped with
0.125 M glycine. Samples were resuspended in RIPA buffer and
divided into three parts (10,000 cells each). Chromatin was sheared
to 150–500 bp fragments with a Biorupter Plus sonication device
(Diagenode) and precipitated using 1 lg anti-H3K4me3 (Diagen-
ode), anti-H3K27me3 (Abcam), or anti-H3K27ac (Millipore) over-
night at 4°C. Next day, chromatin–antibodies complexes were
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incubated with Dynabeads Protein A (Thermo Scientific) for 2 h at
4°C. Elution of the precipitated chromatin was done at 68°C for 2 h
and reverse cross-linking at 65°C for 5 h. ChIP-DNA was purified by
treatments with Proteinase K (Thermo Scientific), RNase A (Thermo
Scientific), and standard phenol:chloroform: isoamylalcohol extrac-
tion and amplified using the SeqPlex amplification Kit (Sigma-
Aldrich). ChIP assay buffers are described (Weishaupt & Attema,
2010).
Quality and quantity of the ChIP-DNA were assessed using
TapeStation (Agilent Technologies). Library preparation was
performed with the TruSeq ChIP sample preparation kit (Illumina
Inc.). End-repair, adapter ligation, and 10 cycles of PCR were done
on 20 ng starting material. Pippin Prep (SageScience) was used for
size selection of the ChIP libraries with a range of 270–350 bp. Final
library was quality checked using the Caliper LabChip GX DNA 1K
Assay and quantified using a picoGreen assay (Invitrogen). ChIP
library was sequenced as 100 pb paired-end run on a HiSeq2500
(Illumina Inc.).
The quality assurance, pre-processing, and peak calling work-
flows were implemented in Galaxy (Goecks et al, 2010). Quality
assurance was performed using the FastaQC (http://www.bioinfor
matics.babraham.ac.uk/projects/fastqc). Reads were aligned against
the Homo sapiens genome using bowtie (Langmead et al, 2009).
BAM files were filtered removing unmapped reads, multi-mapping
reads, and duplicate reads. Finally, peaks were called with MACS
v2.1.0. (Zhang et al, 2008). RPGC normalized coverage (bigwig)
and bedGraph files are created at several steps of the workflow to
visualization of the tracks in the UCSC Genome Browser http://
genome.ucsc.edu.
Immunoprecipitation and Western blotting
For co-IPs, nuclear extracts were prepared from wt CMs transduced
with N-terminally HA-tagged-PPARc and NLS-WT1 14 days after
infection and culturing in adipogenic medium using NE-PER Nuclear
Extraction Kit (Thermo Fisher) according to manufacture’s protocol.
200 lg nuclear lysate was incubated with 2 lg of anti-Wt1 or anti-
HA-tag antibody overnight at 4°C, followed by 1-h incubation with
Protein G Dynabeads (Thermo Fisher). Immunoprecipitates were
extensively washed with PBST, dissolved in Laemmli buffer, and
analyzed by Western blotting. Rabbit IgG was used as a negative
control. Western blot analysis of samples taken before (40 lg of
nuclear extract, input) and after immunoprecipitation was performed
with an anti-Wt1 and anti-PPARc antibodies, followed by light chain
and heavy chain specific secondary HRP-conjugated antibodies,
respectively. Western blotting was performed using standard proto-
cols. Antibodies used for IPs and Western blotting are provided in
Appendix Table S3. Protein band intensities were quantified with
ImageJ.
Immunohistological analysis
Adult mouse hearts and embryos were fixed in 4% paraformalde-
hyde (PFA) for 2 h at 4°C, frozen in OCT, and sectioned at 8 lm.
Human myocardium biopsies from ARVC and non-ARVC patients
were fixed in 4% PFA for 2 h at 4°C, dehydrated, and paraffin
embedded. 8-lm sections were rehydrated, and antigen-retrieval
was performed in the citrate buffer (VECTOR Laboratories). Cells
and EBs were fixed with 4% PFA for 15 min at RT. Samples were
blocked with 10% FBS for 90 min and subjected to a specific
immunostaining at 4°C overnight using primary antibodies as listed
in Appendix Table S3. Phalloidin (Thermo Fisher Scientific) was
used to stain F-actin. AlexaFluor488-, AlexaFluor-594-, AlexaFluor-
647-conjugated secondary antibodies (Thermo Fisher Scientific or
Jackson Immunoresearch) specific to the appropriate species were
used. Nuclei were detected with 1 lg/ml Hoechst 33258. For
immunoperoxidase staining, the VECTASTAIN ABC system
(VECTOR Laboratories) was used. Lipids were stained with BODIPY
(Thermo Fisher Scientific) or ORO.
Microscopy was performed with a DMI6000-AF6000 or a SP8 II
confocal laser-scanning Leica microscope. Images were assigned
with pseudo-colors and processed with ImageJ or Photoshop.
For G-actin quantification, different images were calculated in
which the phalloidin signal was subtracted from the a-actin signal.
The fluorescence intensity over representative cells was quantified
in this difference image and in the corresponding phalloidin image,
and a ratio representing monomeric/filamentous actin was calcu-
lated for each cell.
Glycerol release
To measure lipolysis activity, 8-week-old wt and PKP2mut CMs were
starved overnight and then incubated in DMEM supplemented with
fatty acid-free BSA alone or with 10 lM forskolin (Millipore) for
4 h. The culture medium was collected to measure glycerol using
the free glycerol reagent (Sigma), and cells were then lysed in RIPA
buffer (Sigma) for protein isolation. Glycerol (lg) was normalized to
protein content (mg).
Measurement of active RhoA
Two-month-old wt and PKP2mut CMs were plated on fibronectin-
coated plates. Four days after plating (d0), adipogenic medium was
applied for 1 day (d1). Cells at d0 and d1 were lysed and subjected
to measurement of total and GTP-bound RhoA levels using a
total RhoA ELISA and RhoA activation G-LISA kit, respectively
(Cytoskeleton). Active RhoA was calculated as the RhoA-GTP/total
RhoA ratio.
NLS-WT1, PPARc, and MRTF-A-GFP overexpression and shRNA
silencing of WT1 in CMs
Human PPARc and NLS-WT1 cDNA were cloned into the lentiviral
plasmid pRRLsin18.PPT.PGK.IRES.GFP. In NLS-WT1, the coding
sequence of WT1 is preceded by SV40 large T antigen NLS. PPARc
coding sequence is fused N-terminally with HA-tag. MRTF-A cDNA
C-terminally fused to GFP was inserted into the doxycycline-
inducible lentiviral plasmid pInducer20 (Meerbrey et al, 2011); the
neomycin resistance was replaced by puromycin cassette. For
knockdown of WT1, shRNA oligo was cloned into the doxycycline-
inducible lentiviral plasmid pGLTR-GFP (provided by Lukas Huber,
Biocenter, Innsbruck Medical University, Innsbruck, Austria). As a
control, an shRNA non-targeting oligo (scrambled) was used. Lenti-
viruses were produced as previously described (Dorn et al, 2015).
Wt CMs were transduced with GFP control, NLS-WT1, PPARc and
GFP, or PPARc and NLS-WT1 lentiviruses, and adipogenic treatment
16 of 19 The EMBO Journal e98133 | 2018 ª 2018 The Authors
The EMBO Journal RhoA/MRTF/PPARc in myocyte-to-adipocyte switch Tatjana Dorn et al
Published online: May 15, 2018 
was initiated 3 days after infection. Samples for RNA and immuno-
stainings were collected before infection (d0) and after 7, 12, 14, 21,
and 28 days of culturing in adipogenic medium. Expression of
MRTF-A and shWT1 or scramble was induced with 1 and 0.1 lg/ml
doxycycline (AppliChem), respectively. PKP2mut CMs were infected
with MRTF-A-GFP and treated with adipogenic medium and doxy-
cycline for 28 days.
Live cell imaging of MRTF-A-GFP localization
To visualize MRTF-A subcellular localization at d0 wt, PKP2mut and
MYH10mut CMs were transduced with MRTF-A-GFP and its expres-
sion was induced for 2 days with doxycycline 3 days after infection.
Two days later, the cells were starved in 0.5% FBS for 12 h and
imaged after stimulation with 20% FBS and subsequent incubation
with adipogenic medium for 1 h. To visualize MRTF-A subcellular
localization at day 7, wt and PKP2mut CMs transduced with MRTF-
A-GFP were treated with adipogenic medium 3 days after infection
and MRTF-A-GFP expression was induced for 2 days with doxycy-
cline at d3 of adipogenic culture. At day 7, cells were imaged before
and after application of 20 nM LMB (Calbiochem) for 1 h. For
immunofluorescence analysis, cells at 7 days were treated with
20 nM LMB for 1 h before fixation. To quantify the MRTF-A subcel-
lular localization, nuclear/cytoplasmic ratio of the GFP average
signal intensity of the cells imaged before and after treatment was
calculated.
Transgenic mice and AVV9-mediated transduction
Isl1Cre/+, Isl1MerCreMer/+ (provided by Sylvia Evans, University of
California-San Diego, La Jolla, CA), Wt1CreERT2/+, Myh6Cre/+,
R26YFP/+, and R26mTmG/+ (Jackson Laboratory) mice were used for
lineage-tracing experiments. To induce Cre activity of Isl1MerCreMer/+
and Wt1CreERT2/+, tamoxifen (Sigma-Aldrich) was injected intraperi-
toneally into pregnant females at E7.5 at 3 mg per 40 g body weight.
Recombinant AAV9-NLS-WT1 and AAV9-PPARc vectors were
produced in U293 cells, purified with standard cesium sedimenta-
tion, and tittered as previously described (Ziegler et al, 2013). For
cardiomyocyte-specific transduction, Myh6Cre/+;R26mTmG/+ mice
received 2.5 × 1012 virus particles in the tail vein.
Statistical analysis
Data that passed tests for normality were analyzed with the use of
t-tests for equal (Student’s t-test) or unequal (Welch’s t-test) vari-
ances. For data that were not normally distributed, a Mann–Whit-
ney U-test was applied. P-values of less than 0.05 were considered
statistically significant. All data are shown as means  SEM.
Source data
Microarray expression data have been deposited in the Gene Expres-
sion Omnibus (GEO) under the accession code GSE98525 (https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&acc=GSE98525). Source
data for Figures, Expanded View Figures, and Appendix Figures
have been provided.
Expanded View for this article is available online.
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